---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-056213"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:57:16.431322+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q1 revenue $490.7M (+5.2%), net loss narrows to $11.2M; raises FY2024 guidance

## Summary
- Q1 revenue $490.7M (+5.2% YoY); gross margin $145.9M (29.7% of revenue).
- Net loss improved to $11.2M from $32.0M; diluted EPS loss $(0.06) vs $(0.17).
- Adjusted EBITDA $34.9M (+22.5% YoY), margin 7.1% vs 6.1%.
- FY2024 revenue guidance raised to >$1,970M; adjusted EBITDA raised to >$150M.
- Private Duty Services revenue +$22.1M; Home Health & Hospice revenue -$1.5M.

## SEC filing metadata
- accession: 0000950170-24-056213
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/0000950170-24-056213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/avah-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-056213
- JSON: https://secwatch.observer/filing/0000950170-24-056213.json
- Plain text: https://secwatch.observer/filing/0000950170-24-056213.txt

## Key facts
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported three-month period ended March 30, 2024 results: revenue $490.7 million, net income Net loss was $11.2 million, EPS $(0.06) per diluted share. Guidance raised.
  - Period: three-month period ended March 30, 2024
  - Revenue: $490.7 million
  - Net income: Net loss was $11.2 million
  - EPS: $(0.06) per diluted share
  - Guidance: raised
  - Result: preliminary results
  source text: --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017024056213/0000950170-24-056213-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.